✦ LIBER ✦

COLT, Multicenter CaPre Open Label Randomized Dose-Ranging Phase II Trial to Assess Efficacy/Safety in Patients with Mild-to-High Hypertriglyceridemia

✍ Scribed by Sampalis, Tina; Pesant, Yves; Pouliot, Joel; Elliott, Thomas; Tsoukas, George; Gonzalez, Yolanda; Dufour, Robert; Sampalis, John S.; Lemieux, Pierre; Amiri, Farhad; Waksal, Harlan W.; Davignon, Jean

Book ID: 122329986
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 200 KB
Volume: 8
Category: Article
ISSN: 1933-2874
DOI: 10.1016/j.jacl.2014.02.040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter open-label phase I/II stud

A multicenter open-label phase I/II study to assess the safety, tolerability, and efficacy of three dose levels of TuNEX in patients with rheumatoid arthritis

✍ Der-Yuan Chen; Ning-Sheng Lai; Ling-Ying Lu; Hsiu-Cheng Chou; Yi-Hsing Chen; Tsu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 Chinese ⚖ 428 KB

A Phase 3, multicenter, open-label, swit

A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase

✍ Pastores, Gregory M.; Petakov, Milan; Giraldo, Pilar; Rosenbaum, Hanna; Szer, Je 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 614 KB

Prospective, multicenter, randomized, in

Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancer

✍ Heigener, David F.; von Pawel, Joachim; Eschbach, Corinna; Brune, Andreas; Schmi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Erratum to: A phase II open-label random

Erratum to: A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy

✍ György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 61 KB

A phase II open-label randomized study t

A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy

✍ György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 640 KB

28-week, randomized, multicenter, open-l

28-week, randomized, multicenter, open-label, parallel-group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice-daily injections vs twice-daily injections of biphasic insulin aspart 30 in patients with type 2 diabetes

✍ Takashi Kadowaki; Tomoyuki Nishida; Kohei Kaku 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 201 KB